FDA.reportPublic FDA data

testosterone undecanoate 237 MG Oral Capsule [Jatenzo]

RxCUI
2121776
RxNorm name
testosterone undecanoate 237 MG Oral Capsule [Jatenzo]
Display name
testosterone undecanoate 237 MG Oral Capsule [Jatenzo]
Full name
testosterone undecanoate 237 MG Oral Capsule [Jatenzo]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:26

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
ed7b5d41-7475-4c10-99b9-b62b3434ae60JATENZO 237 MG Oral Capsule [PSN] · testosterone undecanoate 237 MG Oral Capsule [Jatenzo] [SBD] · Jatenzo 237 MG Oral Capsule [SY]312These highlights do not include all the information needed to use JATENZO ® safely and effectively. See full prescribing information for JATENZO. JATENZO (testosterone undecanoate) capsules, for oral use CIII Initial U.S. Approval: 195320250915